← Evidence map

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2021

CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy.

Z Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33948919